DOT1L and retinoblastoma: Since HMGA2 promotes retinoblastoma cell proliferation and regulates DNA damage response, these findings suggest that DOT1L inhibition plays a dual role in chemosensitizing retinoblastoma cells by impairing early DNA damage response and downregulating HMGA2 expression.